Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001837538 | SCV001731087 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2021-12-16 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001553833 | SCV001774902 | benign | Hypercholesterolemia, autosomal dominant, type B | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001553834 | SCV001774903 | benign | Familial hypobetalipoproteinemia 1 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001810748 | SCV002048880 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002368549 | SCV002664333 | benign | Cardiovascular phenotype | 2015-12-10 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
GENin |
RCV002287899 | SCV005074048 | benign | Familial hypercholesterolemia | 2022-06-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001810748 | SCV005245228 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV001528490 | SCV001740314 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001528490 | SCV001925497 | benign | not specified | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV002287899 | SCV002578242 | benign | Familial hypercholesterolemia | 2022-09-19 | no assertion criteria provided | clinical testing |